Tonix Pharm Hldg Cor (TNXP) 6.73 $TNXP Premarket Gainers

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 9:54 PM

Tonix Pharm Hldg Cor (TNXP) 6.73 $TNXP

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 8:22AM CDT

HOG: 56.23 (+0.51), TNXP: 6.73 (+0.21), ALNY: 118.00 (-2.70), LRE: 8.43 (+0.08), LRCX: 78.36 (+0.52), MYL: 72.40 (-1.67), NVGN: 7.40 (-0.30), BIOC: 3.15 (+0.02), NBG: 1.19 (+0.12), VLTC: 15.14 (-1.04), FTNT: 38.07 (-0.01), BCLI: 4.29 (-0.09), SANM: 21.09 (+0.40)

Tonix Pharmaceuticals: Four Data-Based Valuations Of A Deeply Underappreciated Pharmaceutical Company
Jeff Eiseman - at Seeking Alpha - Tue Apr 21, 6:15AM CDT

TNXP: 6.73 (+0.21)

Entries For Seeking Alpha's Contrarian Idea Contest
SA Editor Daniel Shvartsman - Seeking Alpha - Mon Apr 20, 6:21AM CDT
Contrarian thinking is a fundamental part of both active investing and Seeking Alpha - one can't beat the market by agreeing with it. Our latest contest pays homage to that idea. We're looking for the best investment ideas that fit into the...
NFLX: 557.68 (-2.76), BXE: 3.13 (unch), ENPH: 13.38 (+0.03), NEON: 4.45 (+0.23), SEAS: 20.91 (+0.05), TNXP: 6.73 (+0.21), GBX: 64.37 (+0.56), RY: 65.41 (+0.06), INVN: 16.13 (+0.42), PPC: 24.36 (+0.16)

SeeThruEquity Issues Company Update on Tonix Pharmaceuticals, Maintaining Price Target of $14.02
ACCESSWIRE - Tue Apr 07, 6:16PM CDT
NEW YORK, NY / ACCESSWIRE / April 7, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company update on Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP).
TNXP: 6.73 (+0.21)

Biotech Weekly: Top Value Biotech Picks Starting Q2 2015
Daniel Ward - at Seeking Alpha - Mon Mar 30, 8:43AM CDT

LOXO: 13.21 (-0.01), TENX: 3.51 (+0.01), QLTI: 3.75 (-0.04), ECYT: 6.37 (unch), TNXP: 6.73 (+0.21), BOTA: 2.34 (-0.02), XBI: 232.63 (-0.32), DARA: 0.75 (+0.02), IBB: 363.84 (-0.66), MEIP: 2.08 (-0.16)

Tonix Pharmaceuticals to Present at the 12th Annual BIO Asia International Conference
GlobeNewswire - Fri Mar 20, 10:30AM CDT
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a pharmaceutical company with clinical-stage development programs in fibromyalgia, post-traumatic stress disorder (PTSD), and episodic tension-type headache, will present at the 12 Annual BIO Asia International Conference to be held at the Grand Hyatt in Tokyo, Japan. Seth Lederman, M.D., president and CEO of Tonix, will deliver a corporate overview on Tuesday, March 24, 2015 at 11:45 a.m. Japan Time.
TNXP: 6.73 (+0.21)

Tonix Pharma net loss worsens in Q4 and FY14
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 7:49AM CST

TNXP: 6.73 (+0.21)

Tonix reports 4Q loss
Automated Insights - Tue Mar 03, 7:15AM CST
NEW YORK (AP) _ Tonix Pharmaceuticals Holding Corp. (TNXP) on Tuesday reported a loss of $9 million in its fourth quarter.
TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals misses by $0.02
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 7:12AM CST

TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Tue Mar 03, 7:00AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) announced financial results for the fourth quarter and full year ended December 31, 2014. Tonix filed its Annual Report on Form 10-K for fiscal year 2014 on Friday, February 27, 2015.
TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals to Present at the 8th Annual European Life Sciences CEO Forum
GlobeNewswire - Mon Mar 02, 7:40AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) will present at the 8 Annual European Life Sciences CEO Forum & Exhibition in Zurich, Switzerland. Seth Lederman, M.D., Tonix's president and chief executive officer, will deliver a corporate overview on Tuesday, March 3 at 2:30 p.m. local time. Earlier that day, Dr. Lederman will participate as a speaker at a Neuroscience Panel at the conference, to be held at 12:00 p.m. local time.
TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals raises USD28.7m from public offering
M2 - Tue Feb 10, 6:28AM CST
Medicine company Tonix Pharmaceuticals Holding (NasdaqGM:TNXP) disclosed on Monday the completion of its public offering of 4.9m shares of its common stock.
TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals Announces Closing of $28.7 Million Public Offering of Common Stock
GlobeNewswire - Mon Feb 09, 12:45PM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 4,900,000 shares of its common stock. The shares were sold at the public offering price of $5.85 per share, bringing the aggregate gross proceeds from the offering to approximately $28.7 million, before deducting underwriting discounts and commissions and other offering expenses. Investors in the offering included Broadfin Capital LLC, Deerfield Management Company, L.P., Sabby Management LLC and others.
TNXP: 6.73 (+0.21)

Nasdaq stocks posting largest volume increases
AP - Thu Feb 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ADEP: 6.38 (+0.09), TFSC: 9.70 (+0.09), TNXP: 6.73 (+0.21), QKLS: 2.33 (-0.21), EOPN: 8.59 (unch), HPJ: 4.19 (+0.03), PEGI: 29.82 (+0.08), SABR: 25.21 (-0.03), BPFH: 12.50 (+0.13), SBCP: 12.35 (+0.19), ENTR: 3.08 (+0.02), HTWO: 9.70 (-0.11), ACFC: 4.18 (-0.01), OHGI: 1.74 (-0.01)

Tonix Pharmaceuticals to Present at the BIO CEO & Investor Conference
GlobeNewswire - Thu Feb 05, 10:01AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) will present at the 17 Annual BIO CEO and Investor Conference in New York City. Seth Lederman, M.D., Tonix's president and chief executive officer, will deliver a corporate overview on Tuesday, February 10 at 9:30 a.m. ET.
TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals prices public offering of common shares at USD5.85 per share
M2 - Thu Feb 05, 5:48AM CST
Pharmaceutical company Tonix Pharmaceuticals Holding (NasdaqGM:TNXP) said on Wednesday that it has priced a public offering of 4,900,000 shares of its common stock at USD5.85 per share.
TNXP: 6.73 (+0.21)

Tonix Pharma prices equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 8:05AM CST

TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals Prices Underwritten Public Offering of Common Stock
GlobeNewswire - Wed Feb 04, 7:15AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the pricing of an underwritten public offering of 4,900,000 shares of its common stock at a price of $5.85 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 735,000 shares to cover overallotments in connection with the offering. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.7 million, assuming no exercise of the overallotment option. The offering is expected to close on February 9, 2015, subject to customary closing conditions.
TNXP: 6.73 (+0.21)

Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire - Tue Feb 03, 3:18PM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
TNXP: 6.73 (+0.21)

Tonix Shares Looking Attractive As Clinical Programs Advance Forward
Jason Napodano, CFA - at Seeking Alpha - Wed Jan 28, 9:00AM CST

TNXP: 6.73 (+0.21)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endurance Energy's Modular Tech Revs Up Southeast Asia

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Quay Sunglasses: Luxury Looks, Affordable Prices

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

AI and Storytelling Make Waves in Science Education

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

AST SpaceMobile Faces Class Action Over Misstatements

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Timur Turlov Leads FIDE with Chess and Digital Focus

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

China Southern Airlines Marks 70th Anniversary in NYC

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

PACS Group Faces Legal Scrutiny: What to Watch

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Jackson Wang's Fantasy IP Hits Hong Kong Stage

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...